Atlas FDA

APTIMA HPV ASSAY

FDA premarket approval P100042/S007 · decided 2015-11-24

Approval details

PMA number
P100042
Supplement
S007
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
APTIMA HPV ASSAY
Generic name
Kit, rna detection, human papillomavirus
Applicant
Gen-Probe Incorporated
Date received
2015-08-12
Decision date
2015-11-24
Days to decision
104 days
Decision code
APPR
Product code
OYB
Advisory committee
Microbiology
Expedited review
No
Location
San Diego, CA
Statement
APPROVAL FOR A CHANGE TO THE APTIMA HPV ASSAY SOFTWARE FROM VERSION 4.2.0 TO VERSION 4.2.1. THIS CHANGE IS BEING IMPLEMENTED TO REDUCE THE PROBE REAGENT MIXING SPEED IN THE HYBRIDIZATION PROTECTION ASSAY (HPA) INCUBATOR FROM 14 HZ TO 5 HZ ON THE TIGRIS SYSTEM. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME APTIMA® HPV ASSAY. THE APTIMA HPV ASSAY IS AN IN VITRO NUCLEIC ACID AMPLIFICATION TEST FOR THE QUALITATIVE DETECTION OF E6/E7 VIRAL MESSENGER RNA (MRNA) FROM 14 HIGH-RISK TYPES

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
APTIMA TRICHOMONAS VAGINALIS ASSAY (DEN110012)Gen-Probe Incorporated2011-04-19